Advances in peripheral blood stem cell transplantation

Clinical Immunology Newsletter

Volumn 17, Issue 10-11, 1997, Pages 159-162

  Tapp, Heather ^a   To, Luen Bik ^a   Haylock, David ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009842625     PISSN: 01971859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-1859(00)80022-9     Document Type: Article

References (47)

1. Rowlings P: 1996 Summary slides show current use and outcome of blood and marrow transplantation. ABMTR Newsletter, November, 1996.
2. Russell N: The place of blood stem cells in allogeneic transplantation. Br J Haematol 93:747-953, 1996.
3. To LB, Haylock DN, Simmons PJ et al.: The biology and clinical uses of blood stem cells. Blood 89(7):2233-2258, 1997.
4. Simmons PJ, Leavesley DI, Levesque JP et al.: The mobilization of primitive hemopoietic progenitors into the peripheral blood. Stem Cells Dayt 12 Suppl 1:187-201, discussion 201-2, 1994.
5. Turner ML: Regulation of hematopoietic progenitor cell migration, mobilization and homing. Stem Cells Dayt. 12(2):227-9, 1994.
6. Tavassoli M, Hardy CL: Molecular basis of homing of intravenously transplanted stem cells. Blood 1990: 76: 1059-63.
7. Long MW: Blood cell cytoadhesion molecules. Exp Hematol 20(3):288-301, 1992.
8. Simmons PJ, Zannettino A, Gronthos S et al.: Potential adhesion mechanisms for localization of haemopoietic progenitors to bone marrow stroma. Leuk Lymphoma 12(5-6):353-363, 1994.
9. Papayannopoulou T, Nakamoto B: Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA 90(20):9374-9378, 1993.
10. Kerst JM, van de Winkel JG, Evans AH et al.: Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood. 81(6):1457-64, 1993.
11. Kovach NL, Lin N, Yednock T et al.: Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines. Blood 85(1):159-167, 1995.
12. To LB, Haylock DN, Dowse T et al.: A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. Blood 84(9):2930-2939, 1994.
13. Mohle R, Haas R, Hunstein W: Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood. J Hematother. 1993 Winter, 2(4):483-9.
14. Wagner JE, Kernan NA, Steinbuch M et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease [see comments]. Lancet 346(8969):214-9, 1995.
15. To LB et al.: Haematopoietic Stem Cells: The Mulhouse Manual, Alpha Med Press p15-20, 1994.
16. Korbling M, Prezepiorka D, Huh YO et al.: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts [see comments]. Blood 85(6):1659-1665, 1995.
17. Kurtzberg J, Laughlin M, Graham ML et al.: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 335(3):157-166, 1996.
18. Sheridan WP, Begley CG, To LB et al.: Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies [published erratum appears in Bone Marrow Transplant 15(4):654], 1995. Bone Marrow Transplant 14(1):105-11, 1994.
19. Roberts MM, To LB, Gillis D et al.: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant Nov, 12(5):469-75, 1993.
20. Testa U, Martucci R, Rutella S et al.: Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood 84(10):3532-3539, 1994.
21. Bender JG, To LB, Williams S et al.: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1(4):329-41, 1992.
22. Reiffers L et al.: Bone marrow transplantation: Current controversies. Proceedings of Sandoz-UCLA Symposium. New York, NY, Liss, p. 313, 1988.
23. Weaver CH, Hazelton B, Birch R et al.: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy.
24. Schmitz N, Dreger P, Suttorp M et al.: Primary transplatation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]. Blood 85(6):1666-1672, 1995.
25. Bensinger WI, Weaver CH, Appelbaum FR et al.: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor [see comments]. Blood 85(6):1655-1658, 1995.
26. Rusell JA, Luider J, Weaver M et al.: Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 15(1):111-1115, 1995.
27. Ottinger HD, Beelen DW, Scheulen B et al.: Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood. 88(7):2775-2779, 1996.
28. Schmitz N, Bacigalupo A, Labopin M et al.: Transplantation of allogeneic peripheral blood progenitor cells - the EBMT experience. Bone Marrow Transplant. 1996 Mr, 17 Suppl 2: S40-6.
29. Azevedo WM, Aranha FJ, Gouvea JV et al.: Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow Transplant. 16(5):647-653, 1995.
30. Dreger P, Haferlach T, Eckstein V et al.: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Best regards. J Haematol 87(3):609-613, 1994.
31. Takaue Y, Kawano Y, Abe T et al.: Collection and transplantation of peripheral blood stem cells in very small children weighing 20kg or less. Blood 86(1):372-380, 1995.
32. Durand B, Eddleman K, Migliaccio AR et al.: Long-term generation of colony-forming cells (CFC) from CD34+ human umbilical cord blood cells. Leuk-Lymphoma 11(3-4):263-273, 1993.
33. Mayani H, Dragowska W, Lansdorp PM: Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells.
34. Gabutti V, Timeus F, Ramenghi U et al.: Expansion of cord blood progenitors and use for hemopoietic reconstitution. Stem Cells Dayt 11 Suppl 2:105-112, 1993.
35. Nicol AJ, Nieda M et al.: Reliable expansion of LTC-IC in suspension cultures. Blood 86:229a, 1995.
36. Haas R, Mohle R, Fruhauf S et al.: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83(12): 3787-3794, 1994.
37. To LB, Roberts MM, Haylock DN et al.: Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9(4):277-2784, 1992.
38. Henon PR, Liang H, Beck Wirth G et al.: Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 9(4):285-91, 1992.
39. Peters WP, Rosner G, Ross M et al.: Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 81(7):1709-1719, 1993.
40. Sheridan WP, Begley CG, Juttner CA et al.: Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy [see comments]. Lancet. 339(8794):640-644, 1992 .
41. Bensinger W, Singer J, Appelbaum F et al.: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor.
42. Anderlini P, Korbling M et al.: Allogeneic blood stem cell transplantation: considerations for donors. Blood 90: 903-908, 1997.
43. Galy AH, Webb S, Cen D et al.: Generation of T cells from cytokine-mobilized peripheral blood and adult bone marrow CD34+ cells. Blood 84(1):104-110, 1994.
44. Negrin RS, Kusnierz-Glaz CR, Still BJ et al.: Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lumphoma. Blood. 85(11):3334-3341, 1995.
45. Shpall EJ, Jones RB, Bearman SI et al.: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12(1):28-36, 1994.
46. Schiller G, Vescio R, Freytes C et al.: Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86(1):390-397, 1995.
47. Haylock DN, Horsfall MJ, Dows TL et al.: Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood 90:2260-2272, 1997.